Agaimy Abbas, Weichert Wilko
Institute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany.
Institute of Pathology, Technical University of Munich (TUM), Munich, Germany.
Head Neck Pathol. 2017 Dec;11(4):541-545. doi: 10.1007/s12105-017-0783-4. Epub 2017 Feb 7.
The term "sinonasal undifferentiated carcinoma (SNUC)" has been coined in 1986 for a highly aggressive sinonasal tract epithelial neoplasm showing distinctive morphology, but lacking any specific line of differentiation. Recent developments resulted in a dynamic splitting of new entities traditionally included in the spectrum of SNUC. Sinonasal NUT-midline carcinoma, adamantinoma-like Ewing family tumors and most recently, SMARCB1(INI1)-deficient sinonasal carcinoma are the main entities defined by specific genetic aberrations. To our knowledge, involvement of subunits of the SWItch/Sucrose Non-fermentable (SWI/SNF) chromatin remodeling complex other than SMARCB1 has not been implicated in the pathogenesis of SNUC-like neoplasms. We herein describe a 40-year-old woman who presented with a large infiltrative mass involving the right nasal cavity and the sinuses with extension into the skull base and periorbital tissue (cT4N2M0). Biopsies were interpreted initially as poorly differentiated neuroendocrine carcinoma followed by surgical resection and radiochemotherapy. No other extra-nasal tumor was detected on imaging. The patient was alive with disease at last follow-up (9 months from initial diagnosis). Histological evaluation showed poorly differentiated small round blue cell neoplasm with diffuse expression of pancytokeratin but not high molecular weight cytokeratin subsets, CK7, p63, S100, desmin or NUT. Neuroendocrine markers showed limited focal weak reactivity. SMARCB1, SMARCA2 and ARID1A were intact in the tumor cells but SMARCA4 was completely lost. This case highlights the rare occurrence of SMARCA4-deficiency in poorly differentiated sinonasal carcinomas and points to the importance of including other SWI/SNF complex subunits in the evaluation of SMARCB1-intact sinonasal malignancies.
“鼻窦未分化癌(SNUC)”这一术语于1986年被提出,用于描述一种侵袭性很强的鼻窦上皮性肿瘤,其形态独特,但缺乏任何特定的分化方向。最近的研究进展导致了传统上归入SNUC范畴的新实体的动态分化。鼻窦NUT中线癌、釉质瘤样尤因家族肿瘤以及最近发现的SMARCB1(INI1)缺陷型鼻窦癌是由特定基因畸变定义的主要实体。据我们所知,除SMARCB1外,SWItch/蔗糖非发酵(SWI/SNF)染色质重塑复合体的亚基参与SNUC样肿瘤的发病机制尚未见报道。我们在此描述了一名40岁女性,她表现为一个巨大的浸润性肿块,累及右侧鼻腔和鼻窦,并延伸至颅底和眶周组织(cT4N2M0)。活检最初被诊断为低分化神经内分泌癌,随后进行了手术切除和放化疗。影像学检查未发现其他鼻外肿瘤。在最后一次随访(初始诊断后9个月)时,患者带瘤生存。组织学评估显示为低分化小圆形蓝细胞肿瘤,全细胞角蛋白弥漫性表达,但高分子量细胞角蛋白亚群、CK7、p63、S100、结蛋白或NUT均不表达。神经内分泌标志物显示有限的局灶性弱反应性。肿瘤细胞中SMARCB1、SMARCA2和ARID1A完整,但SMARCA4完全缺失。该病例凸显了低分化鼻窦癌中SMARCA4缺陷的罕见性,并指出在评估SMARCB1完整的鼻窦恶性肿瘤时纳入其他SWI/SNF复合体亚基的重要性。